Multiple Assemblies exist for SMTL entry 6o0l
crystal structure of BCL-2 G101V mutation with venetoclax; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 6o0l.1 Ligands 4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl )methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide; DI(HYDROXYETHYL)ETHER; CHLORIDE ION Polypeptides Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2 Oligo-state monomer
	SMTL ID 6o0l.2 Ligands 4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl )methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide; DI(HYDROXYETHYL)ETHER; CHLORIDE ION Polypeptides Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2 Oligo-state monomer